ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2023

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2023
NameSharesValueWeighting ↓
Cubist Systematic Strategies, LLC 162,334$7,488,4610.05%
TWO SIGMA INVESTMENTS, LP 403,774$18,626,0950.05%
Connor, Clark & Lunn Investment Management Ltd. 206,031$9,504,2100.05%
WELLINGTON MANAGEMENT GROUP LLP 5,177,521$238,839,0430.04%
Crestwood Advisors Group, LLC 29,908$1,379,6560.04%
Rafferty Asset Management, LLC 161,675$7,458,0680.04%
Dynamic Technology Lab Private Ltd 7,060$3260.04%
Assenagon Asset Management S.A. 234,468$10,816,0090.04%
Trexquant Investment LP 28,880$1,332,2340.04%
Headlands Technologies LLC 2,224$102,5930.03%
PICTET ASSET MANAGEMENT SA 582,976$26,892,6830.03%
GREAT LAKES ADVISORS, LLC 69,663$3,213,5500.03%
E Fund Management Co., Ltd. 8,693$4010.03%
Jump Financial, LLC 17,141$790,7140.03%
AIGEN INVESTMENT MANAGEMENT, LP 4,420$203,8950.03%
Point72 Middle East FZE 22,704$1,047,3420.03%
ALLIANCEBERNSTEIN L.P. 1,513,767$69,830,0720.03%
HRT FINANCIAL LP 59,300$2,7350.03%
Tower Research Capital LLC (TRC) 16,769$773,5540.03%
BOOTHBAY FUND MANAGEMENT, LLC 24,794$1,143,7470.02%
External links

This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q2 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.